InsiderClue
Stocks · Health care · Pharmaceutical Preparations

MBX Biosciences, Inc.

MBX Clue Score38
United States Fiscal year ends December CIK 0001776111 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Salomon Azoulay
4 Nov 2026
Chief Medical Officer
Sell
373
$53.96
$20.13K
Salomon Azoulay
4 Aug 2026
Chief Medical Officer
Sell
370
$65.77
$24.33K
Salomon Azoulay
8 May 2026
Chief Medical Officer
Sold after exercise
15,003
$38.30
$574.61K
Salomon Azoulay
8 May 2026
Chief Medical Officer
Sold after exercise
55,000
$38.38
$2.11M
P. Kent Hawryluk
6 May 2026
President & CEO
Sell
607
$29.54
$17.93K
Salomon Azoulay
6 May 2026
Chief Medical Officer
Sell
231
$29.54
$6.82K
P. Kent Hawryluk
13 Mar 2026
President & CEO
Buy indirect
18,500
$28.41
$525.66K
P. Kent Hawryluk
26 Feb 2026
President & CEO
Exercised, kept
28,768
$16.00
$460.29K
P. Kent Hawryluk
24 Oct 2025
President & CEO
Exercised, kept
182,859
$3.25
$594.29K
P. Kent Hawryluk
20 Oct 2025
President & CEO
Buy indirect
20,000
$13.64
$272.79K
Steven L. Hoerter
17 Oct 2025
Director
Buy indirect
20,000
$13.25
$264.98K
Patrick J Heron
26 Sep 2025
Director
Buy indirect
666,666
$18.00
$12.00M
Ora H. Pescovitz
8 Apr 2025
Director
Buy
7,693
$5.89
$45.31K
Orbimed Advisors LLC
18 Feb 2025
Director
Buy indirect
94,100
$10.84
$1.02M
Orbimed Advisors LLC
18 Feb 2025
Director
Buy indirect
49,070
$10.84
$531.92K
Carl L Gordon
18 Feb 2025
Director
Buy indirect
94,100
$10.84
$1.02M
Carl L Gordon
18 Feb 2025
Director
Buy indirect
49,070
$10.84
$531.92K
Orbimed Advisors LLC
14 Feb 2025
Director
Buy indirect
29,540
$9.85
$290.97K
Orbimed Advisors LLC
14 Feb 2025
Director
Buy indirect
17,962
$9.90
$177.82K
Carl L Gordon
14 Feb 2025
Director
Buy indirect
29,540
$9.85
$290.97K
Carl L Gordon
14 Feb 2025
Director
Buy indirect
17,962
$9.90
$177.82K
P. Kent Hawryluk
4 Feb 2025
President & CEO
Buy indirect
50,000
$10.69
$534.50K
Carl L Gordon
16 Sep 2024
Director
Buy indirect
250,000
$16.00
$4.00M
Carl L Gordon
16 Sep 2024
Director
Buy indirect
500,000
$16.00
$8.00M
Tiba Aynechi
16 Sep 2024
Director
Buy indirect
750,000
$16.00
$12.00M
Patrick J Heron
16 Sep 2024
Director
Buy indirect
625,000
$16.00
$10.00M
Frazier Life Sciences X, L.P.
16 Sep 2024
10% owner
Buy
625,000
$16.00
$10.00M
New Enterprise Associates 17, L.P.
16 Sep 2024
10% owner
Buy
500,000
$16.00
$8.00M
Orbimed Advisors LLC
16 Sep 2024
Director
Buy indirect
250,000
$16.00
$4.00M
Orbimed Advisors LLC
16 Sep 2024
Director
Buy indirect
500,000
$16.00
$8.00M
Scott D Sandell
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Rick Yang
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Paul Edward Walker
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Mohamad Makhzoumi
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Anthony A. Florence Jr.
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Carmen Chang
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Ali Behbahani
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Forest Baskett
16 Sep 2024
10% owner
Buy indirect
500,000
$16.00
$8.00M
Edward T Mathers
16 Sep 2024
Director
Buy indirect
500,000
$16.00
$8.00M

What was left out

Form 4 filings counted 70
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 49,260,955
History held since 13 Sep 2024